Arcadia Biosciences Annual Income Statement (NASDAQ:RKDA)

Add to My Stocks
$0.69 $0.03 (3.9%) RKDA stock closing price Apr 24, 2017 (Closing)

RKDA stock valuation based on fundamental analysis involves checking and analyzing financial statements and not just the Arcadia Biosciences stock price. The key financial statements of a company are the income statement, the balance sheet and the cash flow statement. The income statement is always for an accounting period, typically for a year or quarter, and affects the stock. In this case, the RKDA stock is bound to reflect the impact of the YoY decline of $2.23M. Along with Arcadia Biosciences assets and Arcadia Biosciences free cash flow, profits as shown in profit and loss statement give key insights about the business. The profits have decreased from $-17.95M YoY and 2016 revenue is $3.18M. Arcadia Biosciences revenue for 2016 is $3.18M. View revenue and profit details for latest and last 10 financial years.

show more
Fiscal year is Jan - Dec. 2016 2015 2014 2013
Arcadia Biosciences Net Sales or Revenues
3.18M5.41M6.98M6.47M
Cost Of Goods Sold (COGS)0.89M0.89M1.99M0.67M
Arcadia Biosciences Gross Profit
2.29M4.52M4.98M5.8M
Research & Development Expense8.66M8.96M10.01M8.4M
Selling General & Admin Expense12.25M11.11M10.12M7.96M
Income Before Depreciation Depletion Amortization-18.62M-15.56M-15.15M-10.56M
Depreciation Depletion Amortization----
Non Operating Income0.34M0.29M-0.59M0.01M
Interest Expense1.31M2.65M1.39M0.62M
Arcadia Biosciences Pretax Income
-19.59M-17.93M-17.14M-11.18M
Provision for Income Taxes0.02M0.02M0.26M0.16M
Minority Interest----
Investment Gains Losses---0.93M-1.84M
Other Income----
Income Before Extraordinaries & Disc Operations-19.62M-17.95M-18.33M-13.19M
Extraordinary Items & Discontinued Operations----
Arcadia Biosciences Net Income (Profit/Loss)
-19.62M-17.95M-18.33M-13.19M
Average Shares used to compute Diluted EPS44.37M28.56M2.06M-
Average Shares used to compute Basic EPS44.37M28.56M2.06M-
Income Before Nonrecurring Items-19.62M-17.73M-18.34M-
Income from Nonrecurring Items--0.23M--
Arcadia Biosciences Earnings Per Share Basic Net
-0.44-0.73-10.71-
Arcadia Biosciences Earnings Per Share Diluted Net
-0.44-0.73-10.71-
EPS Diluted Before Nonrecurring Items-0.44-0.72-10.71-
Preferred Dividends Acc Pd----
Dividends Common----
Dividend Per Share Common----
All figures in USD. M: Millions of USD, B: Billions of USD.
Get Income statement for another ticker

Before investing one should read a report on Arcadia Biosciences stock analysis. It helps to look at the following income statement items:
  • Revenue: This is the inflow that is generated from the sale of goods or services and is $3.18M for this year of 2016. Our Arcadia Biosciences revenue chart gives a clear visual representation of how the topline growth has been. Investors often invest in only those companies where the revenue is growing at a steady rate.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. RKDA stock had a poor bottom line growth.
The income statement is also called the profit and loss statement. Apart from the income statement, one can check the Arcadia Biosciences historical stock prices to check how the price has moved with time. .

Arcadia Biosciences Income Statement - Key Financial Ratios

PS ratio (
price sales ratio
)
9.4978
Operating margin
-1016.7
Net profit margin
-1057.4
Dividend yield
0%